4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-26-069753
Chief Scientific Officer sold 150,000 shares at an average $19.01 ($2,851,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X06/ownership.xml…